The biotech industry in India is expected to show salubrious growth rates in coming years, and is projected to enjoy a CAGR of around 20% between FY2011 & FY2013, says RNCOS in its latest research report, "Booming Biotech Market in India". Future of the industry remains pleasantly buoyant despite the lack of venture funding and stringent regulations in the country. We have found that growth in the biotech industry will be mainly driven by rising R&D expenditure and government support in the form of tax rebates and incentives. Further, the government's initiatives in facilitating implementation of public-private partnerships in the country will further spur industry's optimistic performance.

Cutting edge research in genetic engineering, immunological techniques, cell culture methods, stem cells and hybridoma technology are the main reason driving the growth of Indian biotech market. Additionally, a well established Indian pharmaceutical industry will also lead to a slew of innovative products in the coming years. Various factors that will propel the growth of biotech market in India over the forecast period (FY 2011-FY 2013) are also evaluated.

Besides this, extensive research and prudent analysis of the sub-segments of the biotech industry has been done. We have identified that various factors, such as increasing prevalence of various chronic diseases and increasing penetration of health insurance will boost the biopharma sector of the nation. Moreover, an insight into the role of domestic as well as multinational companies which have stimulated rapid growth of the Indian Biotech market is also given.

"Booming Biotech Market in India" also provides valuable information on industry's various segments like biopharma, bioservices, bioagriculture, industrial biotechnology and bioinformatics together with the detailed study of the investment opportunities in various regions of the country. Current market trends, industrial developments and competitive landscape have been examined to enable clients understand the market structure and its progress in the years to come. Due consideration has been given to the possible after effects of recession on the industry. It will help clients to have a proper understanding of the current and future outlook of the biotech market in India.

For more information visit: http://www.rncos.com/Report/IM110.htm